SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nuveen New York Select Tax-Free Income Portfolio (NXN) trades at a trailing P/E of 30.4. Trailing earnings yield is 3.29%.
Criteria proven by this page:
- VALUE (60/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
- Trailing Earnings Yield 3.29% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
Overall SharesGrow Score: 60/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NXN
Valuation Multiples
P/E (TTM)30.4
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio21.51
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.40
Book Value / Share$0.00
Revenue / Share$0.56
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.29%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.56 |
$2.48M |
$2.21M |
89.2% |
| 2016 |
$0.06 |
$2.41M |
$241.84K |
10% |
| 2017 |
$0.43 |
$1.75M |
$1.67M |
95.2% |
| 2018 |
$0.65 |
$2.64M |
$2.56M |
97% |
| 2019 |
$0.38 |
$1.57M |
$1.48M |
94.5% |
| 2020 |
$0.83 |
$3.33M |
$3.25M |
97.6% |
| 2021 |
$0.00 |
$1.84M |
$-315.23K |
-17.1% |
| 2022 |
$-0.99 |
$-3.82M |
$-3.9M |
- |
| 2023 |
$0.76 |
$3.07M |
$2.99M |
97.4% |
| 2024 |
$0.40 |
$2.22M |
$1.59M |
71.7% |
